INTERVIEW ACTAVIS

"Germany is not an attractive location for business"

With half-yearly acquisitions between 1999 and 2008 the Icelandic generic drug manufacturer Actavis advanced to become one of the ...more

GERMANY

Sanofi storms generic drug market

French pharmaceutical company Sanofi-Aventis gradually gains importance in German generics market, putting current market leaders under ...more

GENERICS

Teva behind plan in Europe

The Israeli generic drug company Teva increased its turnover by a quarter to 13.9 billion US dollars last year; the profit lay at 2 ...more

PARALLEL TRADE / BLISTER PACKING

Kohl lobbies in Brussels

In the future the German entrepreneur Edwin Kohl will also represent his interests in Brussels. Together with other German parallel ...more

UNITED KINGDOM

Falsification campaign stops at nothing

A dead body in a corridor, an autopsy table, freezers: A drastic poster campaign aims to prevent British consumers from obtaining ...more

GENERIC MANUFACTURERS

Dethlefs new general manager at Ratiopharm/Teva

Dr. Sven Dethlefs, previously CEO at Teva Germany, is to become general manager at Ratiopharm. Dethlefs will be responsible for all ...more

GENERIC MANUFACTURERS

Teva acquires Ratiopharm

The Israeli generic drug company Teva acquires German manufacturer Ratiopharm. The purchase price for Germany's second largest generics ...more

MARGINAL NOTE

Pfizer saves Christmas with dog

It's not easy to become the world's largest pharmaceutical manufacturer. Entrepreneurial spirit, precise marketing strategies and a ...more

MERCKLE EMPIRE

Ratiopharm is well received

The Merckle Group can evidently expect a high price for the sale of the Ulm generic drug manufacturer Ratiopharm. According to agency ...more

 DISCOUNT CONTRACTS

European Commission stops proceedings

As early as April, the European Commission stopped infringement proceedings against Germany with respect to discount contracts for ...more
Pages:  1  2  3  4  5  > 

Tools

News Alert
 RSS
 Mobile
 Home
 Dossier

  EU Special

  Phoenix Special

Newsletter

Get your weekly dose. Subscribe now to free newsletter.

Advertise with us

Create new account

Login:

Password:


Forgot Password?
Copyright © 2008, PHARMA ADHOC is a service provided by EL PATO Ltd. - Agentur für Kommunikation. Friedenstraße 91a / 10249 Berlin / Managing Directors: Patrick Hollstein, Elke Hinkelbein / Local Court Berlin Charlottenburg / HRB 100 205 B / sales tax id #: DE246500697. EL PATO Ltd. is not liable for errors or failures within the operational functions, for supply difficulties, for textual mistakes or mistakes regarding contents, despite cases of gross negligence. Furthermore, our terms and conditions apply. E-Mail: info@pharma-adhoc.com URL: www.pharma-adhoc.com We do not guarantee for the correctness of the information. Please also take note of our terms and conditions, terms of use, privacy policy and imprint.